Company / Tangible Book Value per Share
RHYTHM PHARMACEUTICALS, INC. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$2.23
FY2025
5-year range
$0.37 / $5.73
FY2021-FY2025
Trend
+509.6%
vs FY2024
Sector context
#139 of 209
Health Care
What the data says
Tangible Book Value per Share changed +510% YoY in FY2025, a notable deviation from the 9-year average annual change of +96%.
Based on SEC 10-K filings.
2.23 in FY2025 with a 5-year CAGR of -10.0%.
Declined from $3.00 to $2.23 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -24.0%
- 5-Year CAGR
- -10.0%
- 10-Year CAGR
- -
Sector benchmark
#139 of 209 in Health CareTop 67% of 209This company $2.23 Sector average $93.47
▼
-97.6% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 509.6% year-over-year.
- Ranks #139 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2017.
- Lowest tangible book value per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -2.52 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.23 | +509.6% |
| FY2024 | $0.37 | -87.8% |
| FY2023 | $3.00 | -40.9% |
| FY2022 | $5.07 | -11.5% |
| FY2021 | $5.73 | +51.8% |
| FY2020 | $3.77 | -51.1% |
| FY2019 | $7.72 | -14.5% |
| FY2018 | $9.03 | -36.4% |
| FY2017 | $14.20 | +542.7% |
| FY2016 | -$3.21 | -308.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026